| Page 1197 | Kisaco Research
 

Lan Cao

VP, Head of Cell Therapy Innovation Group
Takeda

Lan Cao

VP, Head of Cell Therapy Innovation Group
Takeda

Lan Cao

VP, Head of Cell Therapy Innovation Group
Takeda
 

Mark Plavsic

Chief Technical Officer
Fate Therapeutics

Mark Plavsic

Chief Technical Officer
Fate Therapeutics

Mark Plavsic

Chief Technical Officer
Fate Therapeutics
 

Allison Hubel

Director
Technological Leadership Institute, University of Minnesota

Allison Hubel

Director
Technological Leadership Institute, University of Minnesota

Allison Hubel

Director
Technological Leadership Institute, University of Minnesota

ESG Testimonial 1

The summit was fantastic! The speakers were well selected, and the presentations were helpful especially as I begin viewing our business through the ESG lens.

 

Stefan Frank

Associate Director iPSC Platform Strategy
Bayer

Stefan Frank

Associate Director iPSC Platform Strategy
Bayer

Stefan Frank

Associate Director iPSC Platform Strategy
Bayer
 

Gregory Fiore

CEO
Exacis Biosciences

Gregory Fiore

CEO
Exacis Biosciences

Gregory Fiore

CEO
Exacis Biosciences
 

Jay Mills

Director of Process Development
Century Therapeutics

Jay Mills

Director of Process Development
Century Therapeutics

Jay Mills

Director of Process Development
Century Therapeutics
 

Nicholas Boyd

Chief Development Officer
Cartherics

Nicholas Boyd

Chief Development Officer
Cartherics

Nicholas Boyd

Chief Development Officer
Cartherics
 

Kevin D’Amour

CSO
Brooklyn ImmunoTherapeutics

Kevin D’Amour

CSO
Brooklyn ImmunoTherapeutics

Kevin D’Amour

CSO
Brooklyn ImmunoTherapeutics